|
⚲
|
| Keyboard |
| Wooldridge James
✚
|
|
|---|---|
| CIK # | 0001710641 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001710641] | |
| 4 | [0001710641] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Checkmate Pharmaceuticals Inc | |
| Wooldridge James | |
| Spyre Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Checkmate Pharmaceuticals Inc CMPI
Stock Option (Right to Buy) · derivative
|
2022-05-31 | Disposed to issuer | 101,180 | ||
|
Checkmate Pharmaceuticals Inc CMPI
Stock Option (Right to Buy) · derivative
|
2022-05-31 | Disposed to issuer | 150,818 | ||
|
Checkmate Pharmaceuticals Inc CMPI
Stock Option (Right to Buy) · derivative
|
2022-05-31 | Disposed to issuer | 27,300 | ||
|
Checkmate Pharmaceuticals Inc CMPI
Stock Option (Right to Buy) · derivative
|
2022-05-31 | Disposed to issuer | 54,600 | ||
|
Checkmate Pharmaceuticals Inc CMPI
Stock Option (Right to Buy) · derivative
|
2022-05-31 | Disposed to issuer | 95,916 | ||
|
Checkmate Pharmaceuticals Inc CMPI
Stock Option (Right to Buy) · derivative
|
2022-01-27 | Grant | 101,180 | $0.00 | |
|
Checkmate Pharmaceuticals Inc CMPI
Stock Option (Right to Buy) · derivative
|
2021-08-04 | Grant | 27,300 | $0.00 | |
|
Checkmate Pharmaceuticals Inc CMPI
Stock Option (Right to Buy) · derivative
|
2021-03-04 | Grant | 54,600 | $0.00 | |
|
Checkmate Pharmaceuticals Inc CMPI
Stock Option (Right to Buy) · derivative
|
2020-08-06 | Grant | 150,818 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Employee Stock Option (right to buy) · derivative
|
2019-02-28 | Grant | 50,200 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Employee Stock Option (right to buy) · derivative
|
2018-02-20 | Grant | 45,000 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Employee Stock Option (right to buy) · derivative
|
2017-08-22 | Grant | 10,000 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Employee Stock Option (right to buy) · derivative
|
2017-08-22 | Grant | 165,000 | $0.00 |